Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 2
More JCP Articles
Insights
What are the Efficacy and Safety of Muscarinic Receptor Modulators in Patients With Schizophrenia?
November 19, 2024
In this video, Dr. Correll examines the therapeutic potential of the muscarinic receptor system in schizophrenia treatment. He discusses how targeting muscarinic receptors may address cognitive and functional impairments,…
Insights
What is the Place of Muscarinic Receptor Modulators in the Clinical Care of Patients With Schizophrenia?
November 19, 2024
This video features Dr. Christoph Correll discussing the clinical application of muscarinic receptor modulators in schizophrenia treatment. He explores their unique mechanism of action, compares them to traditional antipsychotics,…
Academic Highlights
Dysregulation of Noradrenergic Activity
November 8, 2024
Dysregulation of noradrenergic activity plays a key role in symptom presentation in major depressive disorder, schizophrenia, Alzheimer’s agitation, and PTSD. This article provides an expert panel’s consensus regarding the…
Insights
Prevalence and Determinants of Everyday Disability in Schizophrenia
October 31, 2024
In this video, Philip D. Harvey, PhD discusses the multifaceted nature of disability in schizophrenia, highlighting the impact of cognitive impairments, functional capacity, and negative symptoms on everyday outcomes…
Clinical and Practical Psychopharmacology
Cannabis Use in Pregnancy and Adverse Outcomes
October 30, 2024
This article focuses on the use of cannabis by women during the reproductive lifespan and specifically during pregnancy, and maternal and neonatal outcomes associated with exposure. Two recent large…
